Drug Utilization Studies – An Overview

DOI:

https://doi.org/10.37285/ijpsn.2010.3.1.2

Authors

  • Shalini S
  • Ravichandran V
  • Saraswathi R
  • BK Mohanty
  • Dhanaraj S K

Abstract

 Aspire of the Drug Utilization Studies (DUS) is to appraise factors related to the prescribing, dispensing, administering and taking of medication, and it’s associated. Since the middle of twentieth century, interest in DUS has been escalating, first for market-only purposes, then for appraising the quality of medical prescription and comparing patterns of use of specific drugs. The scope of DUS is to evaluate the current state and future trends of drug usage, to estimate roughly disease pervasiveness, drug expenditures, aptness of prescriptions and adherence to evidence-based recommendations. The increasing magnitude of DUS as a valuable investigation resource in pharmacoepidemiology has been bridging it with other health allied areas, such as public health, rational use of drug, evidence based drug use, pharmacovigilance, pharmacoeconomics, eco-pharmacovigilance and pharmacogenetics.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Drug utilization studies, drug utilization evaluation, pharmacoepidemiology, epidemiology, drug utilization research

Downloads

Published

2010-05-31

How to Cite

1.
S S, V R, R S, Mohanty B, S K D. Drug Utilization Studies – An Overview. Scopus Indexed [Internet]. 2010 May 31 [cited 2024 Nov. 19];3(1):803-10. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/470

Issue

Vol. 3 No. 1 (2010): April-June 2010

Section

Review Articles
Crossref
Scopus
Google Scholar
Europe PMC

References

APhA special report. Opportunities for the community pharmacist in managed care. Washington: American Pharmaceutical Association. 1994.

Bakssas I, and Lunde PKM. National drug policies: the need for drug utilization studies. Trends Pharmacol. Sci. 7:331-334 (1986).

Boethius G, and Wilman F. Recording of drug prescriptions in the country of Jamtland, Sweden. I. Methodological aspects. Eur. J. Clinical Pharmacol. 12:31-35 (1977).

Braga TB, Pfaffenbach G, Weiss DP, Barros MB, and Bergsten-Mendes G. Point prevalence of drug prescriptions for elderly and non-elderly inpatients in a teaching hospital. Sao. Paulo Med. J. 122(2):48-52 (2004).

Brekke M, Hunskaar S, and Straand J. Self-reported drug utilization, health, and lifestyle factors among 70-74 year old community dwelling individuals in Western Norway. The Hordaland Health Study (HUSK). BMC Public Health, 6:121 (2006).

Costa J, Rosa MM, Ferreira JJ, Sampaio C, and Vaz Carneiro A. Cardiac effects of acute poisoning with tricyclic antidepressants; systematic review of the literature, Part I. Rev. Port. Cardiol. 20:671-678 (2001).

Duarte-Ramos F, and Cabrita J. Using a pharmaco-epidemiological approach to estimate diabetes type 2 prevalence in Portugal. Pharmacoepidemiol Drug Saf. 15:269-274 (2006).

Einarsson TR, Bergman U, and Wiholm, BE. Principles and practice of pharmacoepidemiology, in Speight TM, Holford NH, (eds), Avery’s Drug Treatment. Adis International. pp 371-392, 1999.

Gama H. Drug utilization studies. Arqui. Med. 22(2/3):69-74 (2008).

Goodman MT, Nomura AM, Wilkens LR, and Kolonel LN. Agreement between interview information and physician records on history of menopausal estrogen use. Am. J. Epidemiol. 131:815-825 (1990).

Hartz I, Sakshaug S, Furu K, Engeland A, Eggen A, and Njolstad I. Aspects of statin prescribing in Norwegian countries with high, average and low statin consumption – an individual-level prescription database study. BMC Clinical Pharmacology, 7: 14 (2007).

Hawkey CJ, Hodgson S, Norman A, Daneshmend TK, and Garner ST. Effect of reactive pharmacy intervention on quality of hospital prescribing. BMJ, 300:986-990 (1990).

Hess RD. Retrospective Studies and Chart Reviews. Respiratory Care, 49:1171-1174 (2004).

Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. J. Am. Geriatr. Soc. 39:1079-1084 (1991).

Joint Commission on the Accreditation of Healthcare Organizations. Comprehensive accreditation manual for hospitals. Oakbrook Terrace. 1995.

Klungel OH, D Boer A, Paes AH, Hering RM, Seidell JC, and Bakker A. Influence of question structure on the recall of self-reported drug use. J. Clinic. Epidemiol. 52: 273-277 (2000).

Klungel OH, D Boer A, Paes AH, Hering RM, Seidell JC, and Bakker A. Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in the Netherlands. Pharmacy World & Science. 21:217-220 (1999).

Krivoy N, El-Ahal WA, Bar-Lavie Y, and Haddad S. Antibiotic prescription and cost patterns in a general intensive care unit. Pharm Pract. 5(2):67-73 (2007).

Lau HS, de Boer A, Beuning KS, and Porsius A. Validation of pharmacy records in drug exposure assessment. J. Clin. Epidemiol. 50:619-625 (1997).

Lee D, and Bergman U. Studies of drug utilization. in Strom B, (eds), Pharmacoepidemiology, 3rd ed., Chichester, J Wiley, England, pp 463-481, 2000.

Loyola Filho AI, Uchoa E, Firmo Jde O, and Lima-Costa MF. A population-based study on use of medications by elderly Brazilians: the Bambui Health and Aging Study (BHAS). Cad. Saude Publica. 21(2):545-553 (2005).

Lunde PK, Baksaas I. Epidemiology of drug utilization basic concepts and methodology. Acta Med. Scand. Suppl. 721:7-11 (1988).

Nehru M, Kohli K, Kapoor B, Sadhotra P, Chopra V, and Sharma R. Drug utilization study in outpatient ophthalmology department of government medical college Jammu. JK Science, 7:149-151 (2005).

Neutel CI, Walop W. Comparing two different approaches to measuring drug use within the same survey. Chronic Diseases in Canada, 21:150-156 (2000).

Palumbo FB, Ober J. Drug use evaluation, in Principles and practices of managed care pharmacy. Academy of Managed Care Pharmacy Alexandria (VA), 51-60, 1995.

Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, and Lyles M. Assessing the use of medications in the elderly: methods and initial experience in the cardiovascular health study. J. Clin. Epidemiol. 45:683-692 (1992).

Romano-Lieber NS, Teixeira JJ, Farhat FC, Ribeiro E, Crozatti MT, and de Oliveira GS. A literature review on pharmacists' interventions in the use of medication by elderly patients. Cad. Saude Publica. 18(6):1499-1507 (2002).

Sathvik BS., Drug utilization review/evaluation, in Parthasarathi G, Nyfort-Hansen K, Nahata MC (eds), A textbook of clinical pharmacy practice. 1st ed., Orient Longman, India, pp 362-375, 2004.

Serradell J, Bjornson DC, and Hartzema AG. Drug utilization study methodologies: national and international perspectives. Drug Intell. Clin. Pharm. 21:994-1001 (1987).

Sjahid SI, van der Linden PD, and Stricker BH. Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly study. BJC Pharmacology. 45:591-595 (1998).

Sjoqvist F, and Birkett D. Drug Utilization, in Introduction to drug utilization research. WHO publications, 76-84 (2003).

Strom BL, and Stephen EK (eds), Pharmacoepidemiology. 4th ed., John Wiley & Sons, England, 2005.

Sutharson L, Hariharan RS, and Vamsadhara C. Drug utilization study in diabetology outpatient setting of a tertiary hospital. Indian J. Pharmacol. 35:237-240 (2003).

Van den Brandt PA, Petri H, Dorant E, Goldbohm RA, and Van-de Crommert S. Comparison of questionnaire information and pharmacy data on drug use. Pharm. Weekbl. Sci.13:91-96 (1991).

West SL, Savitz DA, Koch G, Strom BL, Guess H A, and Hartzema A. Recall accuracy for prescription medications: self-report compared with database information. Am. J. Epidemiol. 142:1103-1112 (1995).

WHO Expert Committee. The Selection of Essential Drugs. Technical report series 615, World Health Organization, Geneva. 1977

WHO. How to investigate drug use in health facilities: selected drug use indicators. WHO / DAP, Geneva, 1:1-87, 1993.

WHO. Sources of data on drug utilization, in Introduction to drug utilization research, 20-25, 2003a.

WHO. Types of Drug Use Information. In: Introduction to Drug Utilization Research.13-19, 2003b.